| Anaemia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0005 affected291 at risk
- EG00110 affected255 at risk
- EG0029 affected449 at risk
|
| Eosinophilia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Febrile neutropenia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0021 affected449 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Leukopenia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Lymphadenopathy | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Lymphoid tissue hyperplasia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Pancytopenia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Angina unstable | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Cardiac tamponade | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Cardiopulmonary failure | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cor pulmonale | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Intracardiac thrombus | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Ischaemic cardiomyopathy | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Right ventricular failure | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Fanconi syndrome | Congenital, familial and genetic disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Ear pain | Ear and labyrinth disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Cataract | Eye disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Retinal artery embolism | Eye disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Retinal detachment | Eye disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Vision blurred | Eye disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0005 affected291 at risk
- EG0012 affected255 at risk
- EG0028 affected449 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Anal haemorrhage | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Anal ulcer | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Aphthous stomatitis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Appendicitis perforated | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG00010 affected291 at risk
- EG0015 affected255 at risk
- EG0027 affected449 at risk
|
| Diverticular perforation | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Enteritis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Faecal incontinence | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Faeces discoloured | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Gastrointestinal disorder | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Impaired gastric emptying | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Intestinal perforation | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Irritable bowel syndrome | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Lip ulceration | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Mesenteric vein thrombosis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0013 affected255 at risk
- EG0023 affected449 at risk
|
| Oesophageal pain | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Oesophageal stenosis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Oesophageal ulcer | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Oral disorder | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Oral pain | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0023 affected449 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0022 affected449 at risk
|
| Peptic ulcer | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Peritoneal adhesions | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Proctitis | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0014 affected255 at risk
- EG0024 affected449 at risk
|
| Adverse drug reaction | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Asthenia | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0026 affected449 at risk
|
| Chest pain | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0006 affected291 at risk
- EG0013 affected255 at risk
- EG0023 affected449 at risk
|
| Chills | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Cyst | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Death | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Drug withdrawal syndrome | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Fatigue | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| General physical health deterioration | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0022 affected449 at risk
|
| Generalised oedema | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Influenza like illness | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Local swelling | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Malaise | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Multi-organ failure | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0023 affected449 at risk
|
| Oedema peripheral | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Pain | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Polyserositis | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Pyrexia | General disorders | MedDRA 11.1 | Systematic Assessment | | - EG00014 affected291 at risk
- EG00113 affected255 at risk
- EG00219 affected449 at risk
|
| Acute hepatic failure | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0013 affected255 at risk
- EG0021 affected449 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Cytolytic hepatitis | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Hepatic failure | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Hepatosplenomegaly | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Hepatotoxicity | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Hyperbilirubinaemia | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Jaundice | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Jaundice cholestatic | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Liver injury | Hepatobiliary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Anaphylactic shock | Immune system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Immune reconstitution syndrome | Immune system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Immunodeficiency | Immune system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| AIDS dementia complex | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| AIDS encephalopathy | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Abdominal wall abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Abscess limb | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Abscess neck | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Acanthamoeba infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Acquired immunodeficiency syndrome | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Anal abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0021 affected449 at risk
|
| Anogenital warts | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Anorectal cellulitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Appendiceal abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Appendicitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0024 affected449 at risk
|
| Arthritis bacterial | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Aspergillosis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Bacteraemia | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Bacterial sepsis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Bronchitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0013 affected255 at risk
- EG0020 affected449 at risk
|
| Campylobacter intestinal infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Catheter related infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0023 affected449 at risk
|
| Cellulitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Cellulitis of male external genital organ | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Central line infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Cerebral toxoplasmosis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Choriomeningitis lymphocytic | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Chronic sinusitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Clostridial infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cryptosporidiosis infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cytomegalovirus chorioretinitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Cytomegalovirus colitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Cytomegalovirus infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Cytomegalovirus oesophagitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cytomegalovirus viraemia | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Diarrhoea infectious | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Encephalitis cytomegalovirus | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Encephalitis herpes | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Encephalitis viral | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| End stage AIDS | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Endocarditis bacterial | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Enterocolitis infectious | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Escherichia urinary tract infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Fungal oesophagitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Gastritis fungal | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Giardiasis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Groin abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| HIV infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0013 affected255 at risk
- EG0021 affected449 at risk
|
| Hepatitis viral | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Herpes oesophagitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Herpes simplex | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Herpes zoster | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Klebsiella bacteraemia | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Klebsiella sepsis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Lobar pneumonia | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0013 affected255 at risk
- EG0021 affected449 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Lung abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Lymph node tuberculosis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Mediastinitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Meningitis cryptococcal | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Meningitis pneumococcal | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Molluscum contagiosum | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Mycobacterial infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Mycobacterium avium complex infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0010 affected255 at risk
- EG0023 affected449 at risk
|
| Necrotising herpetic retinopathy | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Oesophageal candidiasis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0012 affected255 at risk
- EG0024 affected449 at risk
|
| Oral candidiasis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0023 affected449 at risk
|
| Orchitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Papilloma viral infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Perineal abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Perirectal abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Pneumococcal infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Pneumococcal sepsis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Pneumocystis jiroveci pneumonia | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0011 affected255 at risk
- EG0028 affected449 at risk
|
| Pneumonia | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0006 affected291 at risk
- EG0019 affected255 at risk
- EG0029 affected449 at risk
|
| Pneumonia bacterial | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0021 affected449 at risk
|
| Pneumonia cytomegaloviral | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Pneumonia necrotising | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Pneumonia pneumococcal | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Pneumonia staphylococcal | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Progressive multifocal leukoencephalopathy | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0014 affected255 at risk
- EG0021 affected449 at risk
|
| Pseudomembranous colitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Pseudomonal sepsis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Pulmonary tuberculosis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Rectal abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Respiratory tract infection viral | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Scrotal abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Sepsis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Septic shock | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Sinusitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0004 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Sinusitis aspergillus | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Sinusitis bacterial | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0012 affected255 at risk
- EG0021 affected449 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Streptococcal infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Streptococcal sepsis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Subcutaneous abscess | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Syphilis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Urinary tract infection enterococcal | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Viral infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Viral sinusitis | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Viral upper respiratory tract infection | Infections and infestations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Burns third degree | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Cerebral haemorrhage traumatic | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Injury | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Neck injury | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Patella fracture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Post procedural haematoma | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0022 affected449 at risk
|
| Skeletal injury | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Splenic rupture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Stress fracture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Transfusion reaction | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Traumatic brain injury | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Wound | Injury, poisoning and procedural complications | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Alanine aminotransferase increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Aspartate aminotransferase increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Biopsy breast | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Blood bilirubin increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Blood creatine phosphokinase increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Blood creatinine increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Blood lactate dehydrogenase increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Blood urea increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Fungus serology test positive | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Gamma-glutamyltransferase increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Haematocrit decreased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Haemoglobin decreased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Hepatic enzyme increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0013 affected255 at risk
- EG0020 affected449 at risk
|
| Liver function test abnormal | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Liver scan abnormal | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Transaminases increased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Weight decreased | Investigations | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Cachexia | Metabolism and nutrition disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0025 affected449 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 11.1 | Systematic Assessment | | - EG0004 affected291 at risk
- EG0014 affected255 at risk
- EG0029 affected449 at risk
|
| Electrolyte imbalance | Metabolism and nutrition disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Failure to thrive | Metabolism and nutrition disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Fat redistribution | Metabolism and nutrition disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Malnutrition | Metabolism and nutrition disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Bone erosion | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Flank pain | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Osteonecrosis | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0006 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Rhabdomyolysis | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Spondyloarthropathy | Musculoskeletal and connective tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Acute myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Anal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0004 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Anal cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Anal cancer stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Bowenoid papulosis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Burkitt's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Colorectal carcinoma stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Diffuse large B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Hodgkin's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Hodgkin's disease stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Kaposi's sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0023 affected449 at risk
|
| Laryngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Malignant anorectal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Non-Hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Penis carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Plasmablastic lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Splenic neoplasm malignancy unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Brain oedema | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Cerebral haematoma | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Convulsion | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0023 affected449 at risk
|
| Encephalitis | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Epilepsy | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Facial palsy | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Haemorrhage intracranial | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Headache | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0025 affected449 at risk
|
| Hypertensive encephalopathy | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Intracranial aneurysm | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Intracranial hypotension | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Lethargy | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Leukoencephalopathy | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Loss of consciousness | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Memory impairment | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Nervous system disorder | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Sinus headache | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Syncope | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Tremor | Nervous system disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Ectopic pregnancy | Pregnancy, puerperium and perinatal conditions | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Anxiety disorder | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Confusional state | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Depression | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0012 affected255 at risk
- EG0021 affected449 at risk
|
| Drug abuse | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Hallucination | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Hallucination, tactile | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Hypomania | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Paranoia | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Suicide attempt | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Withdrawal syndrome | Psychiatric disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Calculus ureteric | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Focal glomerulosclerosis | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Glomerulonephritis proliferative | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Nephritis interstitial | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Oliguria | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Renal colic | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0003 affected291 at risk
- EG0013 affected255 at risk
- EG0024 affected449 at risk
|
| Renal failure acute | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0008 affected291 at risk
- EG0012 affected255 at risk
- EG0024 affected449 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Renal tubular acidosis | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Renal tubular disorder | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Renal tubular necrosis | Renal and urinary disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Breast pain | Reproductive system and breast disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Cervical dysplasia | Reproductive system and breast disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Epididymitis | Reproductive system and breast disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Fallopian tube obstruction | Reproductive system and breast disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Haematosalpinx | Reproductive system and breast disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Metrorrhagia | Reproductive system and breast disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Prostatitis | Reproductive system and breast disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Asphyxia | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Bronchospasm | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0021 affected449 at risk
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0014 affected255 at risk
- EG0022 affected449 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0022 affected449 at risk
|
| Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Lower respiratory tract inflammation | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Lung disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0023 affected449 at risk
|
| Pneumomediastinum | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Productive cough | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Respiratory disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0021 affected449 at risk
|
| Snoring | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Tachypnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Drug eruption | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0021 affected449 at risk
|
| Lipodystrophy acquired | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Lipohypertrophy | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0002 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Rash pruritic | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0012 affected255 at risk
- EG0020 affected449 at risk
|
| Skin exfoliation | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Skin lesion | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Skin toxicity | Skin and subcutaneous tissue disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Colostomy | Surgical and medical procedures | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Intestinal anastomosis | Surgical and medical procedures | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Intestinal operation | Surgical and medical procedures | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Lymphadenectomy | Surgical and medical procedures | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Umbilical hernia repair | Surgical and medical procedures | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Wisdom teeth removal | Surgical and medical procedures | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Air embolism | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Hypertension | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0023 affected449 at risk
|
| Hypotension | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0022 affected449 at risk
|
| Hypovolaemic shock | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Lymphocele | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0011 affected255 at risk
- EG0020 affected449 at risk
|
| Necrosis ischaemic | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|
| Varicose vein | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0000 affected291 at risk
- EG0010 affected255 at risk
- EG0021 affected449 at risk
|
| Venous occlusion | Vascular disorders | MedDRA 11.1 | Systematic Assessment | | - EG0001 affected291 at risk
- EG0010 affected255 at risk
- EG0020 affected449 at risk
|